naltrexone has been researched along with erythrosine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archer, S; Bidlack, JM; Hutchinson, I; Lawrence, DM; Seyed-Mozaffari, A | 1 |
Booze, RM; Dodson, SL; Nath, A; Wallace, DR | 1 |
Heller, NM; Maher, DP; Walia, D | 1 |
3 other study(ies) available for naltrexone and erythrosine
Article | Year |
---|---|
Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin.
Topics: Animals; Biotin; Fluorescein; Fluoresceins; Fluorescent Dyes; Leukocytes; Mice; Naltrexone; Phycoerythrin; Receptors, Opioid, kappa; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1997 |
Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells.
Topics: Benzamides; Cell Line, Tumor; Cell Membrane; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Fluoresceins; Free Radicals; Gene Products, tat; Humans; Molsidomine; Naltrexone; Narcotic Antagonists; Opioid Peptides; Oxidative Stress; Piperazines; Receptors, Opioid, delta; tat Gene Products, Human Immunodeficiency Virus | 2006 |
Suppression of Human Natural Killer Cells by Different Classes of Opioids.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Anesthesia; Buprenorphine; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Fluoresceins; Humans; Immunosuppression Therapy; K562 Cells; Killer Cells, Natural; Loperamide; Methadone; Morphinans; Morphine; Naloxone; Naltrexone; Succinimides; Toll-Like Receptor 4; Tramadol | 2019 |